Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

A Study of the Natural Progression of Interstitial Lung Disease (ILD)

University of Chicago · with Idiopathic Pulmonary Fibrosis Clinical Research Network, National Institute of Allergy and Infectious Diseases (NIAID) · NCT00470327

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
4000
US sites recruiting
1
Study start
September 2005
Record last updated
June 9, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the "phenotypic" expression of these diseases.

Conditions: Interstitial Lung Diseases; Idiopathic Pulmonary Fibrosis; Sarcoidosis; Connective Tissue Disorder

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Interstitial lung disease

Exclusion Criteria

  • Does not have Interstitial lung disease

Recruiting US locations

  • University of Chicago

    Chicago, IL 60637

    Site contact: Mary E Strek, MD · 773-702-3609 · mstrek@medicine.bsd.uchicago.edu

Study contacts (from the official record)

  • Vanita Patel, MPH · 773-702-1012
A Study of the Natural Progression of Interstitial Lung Disease (ILD) (NCT00470327) | Bored Studies